iBio (IBIO) Payables (2011 - 2026)
iBio (IBIO) recorded Payables of $4.42 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 49.7% from $2.95 million a year earlier and up 45.7% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Payables (2011 - 2026) Analysis & Trends
Starting with fiscal Q4 2011, iBio's Payables history includes 61 quarters.
- Annual Payables has a five-year compound annual growth rate of 9.2% (FY2021 to FY2026).
- Across earlier fiscal years, Payables came in at $2.95 million in FY2025 (+412.8%), $576,000 in FY2024 (-96.1%), $14.79 million in FY2023 (-44.0%) and $26.43 million in FY2022 (+825.9%).
- The fiscal Q4 2026 figure is the highest quarterly Payables since fiscal Q3 2024.
- On a year-over-year basis, Payables has increased for five consecutive quarters, with growth averaging 71.4% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 825.9% in fiscal Q4 2022, against a decline of 96.1% in fiscal Q4 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $3.04 million (Q3 2026), $2.65 million (Q2 2026) and $3.53 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | iBio | 121.75 Mn | 121.75 Mn | - | 4.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.42 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 3.53 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 2.30 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 576,000.00 |
| Mar 31, 2024 | 13.88 Mn |
| Dec 31, 2023 | 14.51 Mn |
| Sep 30, 2023 | 14.54 Mn |
| Jun 30, 2023 | 14.79 Mn |
| Mar 31, 2023 | 15.71 Mn |
| Dec 31, 2022 | 20.01 Mn |
| Sep 30, 2022 | 27.01 Mn |
| Jun 30, 2022 | 26.43 Mn |
| Mar 31, 2022 | 5.28 Mn |
| Dec 31, 2021 | 2.74 Mn |
| Sep 30, 2021 | 2.29 Mn |
API Access
iBio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();